A Study of RBD1016 in CHB Participants

NCT05961098 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

48

Enrollment

INDUSTRY

Sponsor class

Conditions

Chronic Hepatitis b

Interventions

DRUG: RBD1016

Sponsor

Suzhou Ribo Life Science Co. Ltd.